InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,186.54
(
0.11%
)
US TECH 100
17,641.60
(
0.18%
)
Dow Jones
38,923.12
(
0.18%
)
Brent Oil
82.68
(
-0.96%
)
Bitcoin
63,199.09
(
0.05%
)
Post# of 2954
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

JK2016

Send PM Follow Ignore
Followers 1
Posts 103
Boards Moderated 0
Alias Born 05/18/2016

JK2016

Re: None

Wednesday, 10/06/2021 11:30:07 AM

Wednesday, October 06, 2021 11:30:07 AM

Post# of 2954
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage
biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today
announced that new preclinical data for EDP-235, its lead oral protease inhibitor specically designed for the
treatment of COVID-19, will be presented at the International Society for Inuenza and Other Respiratory Virus
Diseases (ISIRV)-World Health Organization Virtual Conference (WHO): COVID-19, Inuenza and RSV: SurveillanceInformed Prevention and Treatment. The conference is being held virtually on October 19 – October 21, 2021.
Poster Presentation:

Date: October 19, 2021
Time: 8:00 a.m. CET
Poster #120: “EDP-235, A Potential Oral, Once-Daily Antiviral Treatment and Preventative for COVID-19”
Presenter: Li-Juan Jiang, Ph.D.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ENTA News
More ENTA News
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Start posting your company's news
Only $200 per official company press release!